869 related articles for article (PubMed ID: 32631771)
1. COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult.
Sokolovsky S; Soni P; Hoffman T; Kahn P; Scheers-Masters J
Am J Emerg Med; 2021 Jan; 39():253.e1-253.e2. PubMed ID: 32631771
[TBL] [Abstract][Full Text] [Related]
2. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
Zhang QY; Xu BW; Du JB
World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
[TBL] [Abstract][Full Text] [Related]
3. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
Front Immunol; 2021; 12():632890. PubMed ID: 33732254
[TBL] [Abstract][Full Text] [Related]
4. Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings.
Marzano AV; Cassano N; Moltrasio C; Verdoni L; Genovese G; Vena GA
Dermatology; 2022; 238(1):35-43. PubMed ID: 34062530
[TBL] [Abstract][Full Text] [Related]
5. A case of multisystem inflammatory syndrome in children in a Japanese boy: with discussion of cytokine profile.
Fukuda S; Kaneta M; Miyake M; Ohya T; Miyakawa K; Iwamoto M; Ito S
Mod Rheumatol Case Rep; 2021 Jul; 5(2):442-447. PubMed ID: 33904379
[TBL] [Abstract][Full Text] [Related]
6. Multi-System Inflammatory Syndrome in a Child Mimicking Kawasaki Disease.
Gupta A; Gill A; Sharma M; Garg M
J Trop Pediatr; 2021 Jul; 67(3):. PubMed ID: 32778886
[TBL] [Abstract][Full Text] [Related]
7. Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: An Overview and Comparison.
Darby JB; Jackson JM
Am Fam Physician; 2021 Sep; 104(3):244-252. PubMed ID: 34523885
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2.
Yeo WS; Ng QX
Med Hypotheses; 2020 Nov; 144():110263. PubMed ID: 33254568
[TBL] [Abstract][Full Text] [Related]
9. Kawasaki Shock Syndrome and Covid-19.
Ashraf S; Abbasi FS; Atiq M
J Coll Physicians Surg Pak; 2021 Jul; 31(7):135-137. PubMed ID: 34271815
[TBL] [Abstract][Full Text] [Related]
10. Perineal desquamation: An early sign of the Kawasaki disease phenotype of MIS-C.
Mazori DR; Derrick KM; Kapoor U; Haribhai M; Gist RE; Glick SA
Pediatr Dermatol; 2021 Jan; 38(1):253-256. PubMed ID: 33222290
[TBL] [Abstract][Full Text] [Related]
11. Kawasaki Disease Shock Syndrome vs Classical Kawasaki Disease: A Meta-analysis and Comparison With SARS-CoV-2 Multisystem Inflammatory Syndrome.
Lamrani L; Manlhiot C; Elias MD; Choueiter NF; Dionne A; Harahsheh AS; Portman MA; McCrindle BW; Dahdah N
Can J Cardiol; 2021 Oct; 37(10):1619-1628. PubMed ID: 34090979
[TBL] [Abstract][Full Text] [Related]
12. Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease.
Bukulmez H
Curr Rheumatol Rep; 2021 Jul; 23(8):58. PubMed ID: 34216296
[TBL] [Abstract][Full Text] [Related]
13. Laboratory parameters between multisystem inflammatory syndrome in children and Kawasaki disease.
Zhou C; Zhao Y; Wang X; Huang Y; Tang X; Tang L
Pediatr Pulmonol; 2021 Dec; 56(12):3688-3698. PubMed ID: 34583417
[TBL] [Abstract][Full Text] [Related]
14. Kawasaki disease shock syndrome in the COVID-19 pandemic.
Gámez-González LB; Ramírez-López MJ; Colmenero-Rascón M; Yamazaki-Nakashimada MA
Cardiol Young; 2022 Mar; 32(3):506-507. PubMed ID: 34278987
[TBL] [Abstract][Full Text] [Related]
15. Atypical Kawasaki syndrome in COVID-19 infection: a case report of a multisystem inflammatory syndrome in a child (MIS-C).
Sylverken J; Afari P; Martyn-Dickens C; Owusu SA; Oppong E; Akwetey F; Mensah E; Mahama H; Owusu SK; Antwi S
Ghana Med J; 2021 Jun; 55(2 Suppl):64-67. PubMed ID: 35233117
[TBL] [Abstract][Full Text] [Related]
16. Children with Kawasaki disease or Kawasaki-like syndrome (MIS-C/PIMS) at the time of COVID-19: are they all the same? Case series and literature review.
Marino A; Varisco T; Quattrocchi G; Amoroso A; Beltrami D; Venturiello S; Ripamonti A; Villa A; Andreotti M; Ciuffreda M; Cimaz R
Reumatismo; 2021 Apr; 73(1):48-53. PubMed ID: 33874647
[TBL] [Abstract][Full Text] [Related]
17. Toxic shock-like syndrome and COVID-19: Multisystem inflammatory syndrome in children (MIS-C).
Greene AG; Saleh M; Roseman E; Sinert R
Am J Emerg Med; 2020 Nov; 38(11):2492.e5-2492.e6. PubMed ID: 32532619
[TBL] [Abstract][Full Text] [Related]
18. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
[TBL] [Abstract][Full Text] [Related]
19. The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection.
Berardicurti O; Conforti A; Ruscitti P; Cipriani P; Giacomelli R
Expert Rev Clin Immunol; 2020 Dec; 16(12):1205-1215. PubMed ID: 33152254
[No Abstract] [Full Text] [Related]
20. Distinguishing Multisystem Inflammatory Syndrome in Children From COVID-19, Kawasaki Disease and Toxic Shock Syndrome.
Godfred-Cato S; Abrams JY; Balachandran N; Jaggi P; Jones K; Rostad CA; Lu AT; Fan L; Jabbar A; Anderson EJ; Kao CM; Hunstad DA; Rosenberg RB; Zafferani MJ; Ede KC; Ballan W; Laham FR; Beltran Y; Bryant B; Meng L; Hammett TA; Oster ME; Bamrah Morris S; Belay ED
Pediatr Infect Dis J; 2022 Apr; 41(4):315-323. PubMed ID: 35093995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
